Literature DB >> 24907915

Human chorionic gonadotropin vs. gonadotropin-releasing hormone agonist trigger in assisted reproductive technology--"the king is dead, long live the king!".

Peter Humaidan1, Nikolaos P Polyzos2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24907915     DOI： 10.1016/j.fertnstert.2014.04.047

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


× No keyword cloud information.
  5 in total

1.  Impact of Mid-Luteal Phase GnRH Agonist Administration on Reproductive Outcomes in GnRH Agonist-Triggered Cycles: A Randomized Controlled Trial.

Authors:  Abdelhamid Benmachiche; Sebti Benbouhedja; Abdelali Zoghmar; Amel Boularak; Peter Humaidan
Journal:  Front Endocrinol (Lausanne)       Date:  2017-06-15       Impact factor: 5.555

2.  Efficiency of metaphase II oocytes following minimal/mild ovarian stimulation in vitro fertilization.

Authors:  John J Zhang; Mingxue Yang; Zaher Merhi
Journal:  Fertil Res Pract       Date:  2016-09-01

3.  Ectopic pregnancy risk factors for ART patients undergoing the GnRH antagonist protocol: a retrospective study.

Authors:  A Weiss; R Beck-Fruchter; J Golan; M Lavee; Y Geslevich; E Shalev
Journal:  Reprod Biol Endocrinol       Date:  2016-03-23       Impact factor: 5.211

Review 4.  Progesterone administration for luteal phase deficiency in human reproduction: an old or new issue?

Authors:  Stefano Palomba; Susanna Santagni; Giovanni Battista La Sala
Journal:  J Ovarian Res       Date:  2015-11-19       Impact factor: 4.234

5.  HCG trigger versus GnRH agonist trigger in PCOS patients undergoing IVF cycles: frozen embryo transfer outcomes.

Authors:  Krishna Deepika; Rathore Suvarna; Maria Sumi; Dhoble Snehal; Vohra Arveen; Kamath Anuja; Pranesh Gautham; Rao Kamini
Journal:  JBRA Assist Reprod       Date:  2021-02-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.